Brain-derived neurotrophic factor (BDNF)
A central tenet of Hebbian synaptic plasticity holds that synaptic strengthening requires concurrent pre-and postsynaptic activity. This assertion encompasses the concept of use-or activity-dependence, and provides insight into processes ranging from refinement of synaptic connectivity during development to learning and memory. In the visual system, for example, interventions that inhibit the firing of retinal ganglion neurons can disrupt segregation of afferent fibers into cortical ocular dominance columns (Stryker and Harris, 1986) .
In many systems, the signal underlying activity-dependence is the opening of the NMDA glutamate receptors. NMDA receptor antagonists can disrupt development of visual pathways (For review, see Debski and Cline, 2002) , and can prevent forms of associative synaptic plasticity such as hippocampal long-term potentiation (LTP) (For review, see Bliss and Collingridge, 1993) . Physiological features of the receptor, such as calcium permeability and voltage-dependent magnesium block (Mayer and Westbrook, 1987) make it ideal to signal neuronal activity, leading to the description of this receptor as a "coincidence detector".
NMDA receptor involvement alone, however, cannot explain the multifunctional changes observed in the nervous system. One candidate for additional modulation of synaptic plasticity is the neurotrophin brain-derived neurotrophic factor (BDNF) (For review, see McAllister et al., 1999; Poo, 2001; Tyler et al., 2002; Chao, 2003; Lu, 2004) . In slices of visual cortex, BDNF requires glutamate receptor activity to promote alterations in dendritic morphology (McAllister et al., 1996) . Injection of BDNF into cat visual cortex in vivo inhibited ocular dominance column formation in the vicinity of injection but not elsewhere (Cabelli et al., 1995) , and blockade of endogenous ligand signaling via TrkB, the BDNF receptor, also inhibited ocular dominance column formation (Cabelli et al., 1997) . In accord with this are studies demonstrating the activity-dependence of BDNF release (Balkowiec and Katz, 2000; Balkowiec and Katz, 2002; Magby et al., 2006; Kolarow et al., 2007; Kuczewski et al., 2008) .
Regulation of NMDA receptor-dependent synaptic plasticity by BDNF implies a link between TrkB activation and NMDA receptor activity. Recent studies have revealed such an interaction that may be critical for manifestation of activity-dependence (Jarvis et al., 1997; Song et al., 1998; Levine et al., 1998; Kerr et al., 1999; Crozier et al., 1999; Arvanian and Mendell, 2001; Legrand et al., 2005; Garraway et al., 2005) . We have used glutamate receptor agonists (Levine et al., 1998) and antagonists (Crozier et al., 1999) to show that the predominant postsynaptic effect of BDNF is to enhance selectively the NMDA component of glutamate current. Previous studies, however, have not addressed this critical question:
Will BDNF enhancement of NMDA receptor availability occur in the absence of neuronal activity? In experiments done to date, glutamate receptors were co-activated with BDNF presentation. If BDNF was instead applied in the absence of glutamate receptor activation, would subsequent testing reveal increased NMDA receptor activity or would it be unaffected? If the former, then BDNF modulation is not usedependent and would not be categorized as contributing to Hebbian plasticity. If the latter, the conclusion would be the opposite. To address this issue we employed two different stimulation protocols: an "activity" protocol consisting of relatively high frequency glutamate stimulation and a "low activity" protocol with low frequency stimulation. Our results indicate that NMDA receptor opening and elevation of intracellular calcium are critical for postsynaptic enhancement of NMDA receptor activity by BDNF, and that the NMDA receptors themselves are sufficient to provide the calcium influx.
Methods
Cell culture. High density hippocampal cultures were grown as previously described (Levine et al., 1995) . In brief, time-mated pregnant Sprague-Dawley rats were sacrificed by CO 2 asphyxiation in accordance with institutional guidelines for care and use of animals. Hippocampi were obtained at 18 days gestation and placed into cold PBS. Cells were triturated in 2 ml of Eagle's minimum essential medium (MEM) with added glucose and 10% FBS and plated on poly-D-lysine coated Nunc petri dishes.
Cultures were maintained in serum-free medium (SFM) in a 95% air/5% CO 2 humidified incubator at 37° centigrade. SFM consisted of a 1:1 (vol/vol) mixture of Ham's F-12 (Gibco) and MEM (Gibco) and supplemented with 25 μg/ml insulin, 100 μg/ml transferrin, 60 μM putrescine, 20 nM progesterone, 30 nM selenium, 6 mg/ml glucose, and 0.5 U/ml and 0.5 mg/ml of penicillin and streptomycin, respectively.
Electrophysiology. Whole-cell voltage-clamp recordings were made from pyramidal-type cells after 12-16 days in vitro by standard techniques (Hamill et al., 1981) . Cells were held at a resting potential of -40 mV to reduce Mg ++ blockade of NMDA receptors. For each condition tested, experiments were performed from multiple platings. The external bath solution contained (in mM): 1.67 CaCl 2 , 1 Mg Cl 2 , 5.36 KCl, 137 NaCl, 17 glucose, 10 HEPES, 0.001 TTX, and 20 sucrose. The osmolarity was 325 mOsm. For experiments with zero added calcium in the bath solution the osmolarity was re-adjusted with sucrose.
For anti-BDNF antibody (Promega) experiments, a concentration of 10 μg/ml was added to the external solution. The internal pipette solution contained (in mM): 105 Cs-methanesulfonate, 15 CsCl, 10 HEPES, 0.2 EGTA, 8 NaCl, 2 Mg-ATP, 2 Na 2 -ATP, 0.3 Na 3 -GTP, 20 phosphocreatinine, and 50 creatinine phosphokinase. The pH of the pipette solution was set to 7.3 with CsOH and the osmolarity was 310 mOsm. For experiments with BAPTA included in the pipette solution, EGTA was removed, 10 mM BAPTA was added and Cs-methanesulfonate concentration was reduced to return the osmolarity to control; all other component concentrations remained the same. Signals were recorded with an Axopatch 200 amplifier (Axon Instruments), sampled at 2.5 kHz (INDEC IDA15125 or CED Power1401 interface) and filtered at 5 kHz. Three-barrel micropipettes were used for iontophoretic application of glutamate.
One barrel, filled with 0.1 Μ NaCl, was used for current balancing. Other barrels were filled with either Lglutamate (0.2 M, pH 7.5) or saline control. During baseline recording, typical currents were elicited at 10 sec intervals by 2-10 ms pulses yielding currents with peak amplitudes ranging from 25-50 pA.
Experiments without exogenously applied BDNF followed the same aforementioned stimulation protocols.
For single-channel recording of NMDA receptor activity, cell-attached patches were made from neuronal somata. The intracellular potential was set to approximately 0 mV with a bath solution containing (in mM) 140 potassium gluconate, 10 HEPES, and 5 EGTA, pH 7.5. To activate NMDA receptor channels, 10 μM NMDA and 3 μM glycine were added to a magnesium-free solution containing (in mM) 10 Cs-methanesulfonate, 110 Na 2 SO 4 , 25 HEPES, 33 glucose, 1.3 CaCl 2 , pH 7.35. To isolate NMDA receptor activity, the membrane potential was set to -80 mV which is below the threshold for activating most voltage-gated channels. Channel identity was confirmed as described previously (Levine et al., 1998) . Patches typically contained 1 -3 channels as judged by the presence of overlapping openings.
Patches with larger numbers of channels were not used. Signals were sampled at 5 kHz and filtered at 1 kHz with an intersweep interval of 1 sec. For most patches, activity was quantified by obtaining open times and number of openings from sweeps with non-overlapping openings by idealization with the halfamplitude crossing criterion and cubic spline interpolation (Sigworth and Sine, 1987) . Open probability (Po) was calculated by dividing open time by total time per sweep. All sweeps, including nulls, were included in the calculation of average Po. For two recordings with a large number of overlapping openings, Po was calculated by measuring charge and dividing by maximal possible charge. For all recordings, activity was recorded for at least 10 minutes prior to applying BDNF (baseline). Only recordings for which baseline line activity remained stable for the 5 minutes before BDNF application were used. Recordings in which activity was gradually decreasing or increasing were not used.
All chemicals were from Sigma unless otherwise noted. BDNF (Peprotech) was prepared as a stock in phosphate-buffered saline with 1 µg/ml bovine serum albumin, and diluted 500-fold into bath solution.
K-252a/b (Calbiochem) were prepared as 1000-fold stocks in DMSO. Kynurenate and anti-BDNF antibody were purchased from Tocris and Promega, respectively. Anti-BDNF antibody was heat inactivated by boiling the stock solution at 100 °C for 15 minutes prior to dilution in bath solution to a final concentration of 10 µg/ml. Student's t-test was used with p < 0.05 indicating significance.
Results
Frequency of glutamate stimulation affects BDNF modulation. The overall goal of this study was to determine whether the postsynaptic effect of BDNF on glutamate current required co-activation of glutamate receptors. Whole-cell voltage clamp recordings were obtained from cultured embryonic hippocampal neurons. To allow NMDA receptor openings, the holding potential was set to -40 mV and pulses of glutamate were applied iontophoretically along the initial segment of major dendrites. In addition, presynaptic actions of BDNF were eliminated by addition of TTX to the bath solution. Baseline current amplitudes ranged from 25-50 pA and currents reversed at ~0 mV. To determine whether BDNF enhancement of glutamate-evoked currents requires concurrent neurotransmitter receptor activation, we used two types of stimulation protocols during BDNF exposure (Fig. lA) . Use of an "activity" protocol (six glutamate pulses per minute for the duration of the recording), resulted in a doubling of total glutamate current (184 ± 13% of baseline, n = 8; Fig. 1B ,C) when measured 20-25 minutes during BDNF (20 ng/ml) exposure, a result in accordance with previous studies (Levine et al., 1998; Crozier et al., 1999) .
The experiments above, however, do not answer the question of whether exposure to BDNF, in the absence of concurrent neurotransmitter receptor activation, will still augment glutamate current. This is an important issue because an effect of BDNF in the absence of glutamate receptor activity would argue that BDNF acts postsynaptically in an activity-independent, and thus non-Hebbian, fashion. To address this, we used a "low activity" protocol ( Fig. 1A , single pulses of glutamate delivered every five minutes for the first 20 minutes of BDNF exposure, stimulation at 6 pulses per minute thereafter) which allowed us to periodically assess the stability of the recording while largely eliminating glutamate receptor activation.
With this protocol, the effect of BDNF was significantly reduced (118 ± 11% of baseline, n = 7, p < 0.01; Fig. 1B,C) . Thus, potentiation of glutamate currents by BDNF requires concurrent postsynaptic glutamate receptor activation during BDNF exposure.
Work from other investigators has shown that iontophoretic application of multiple, long pulses of glutamate (10 sec) onto neurons in hippocampal slices can produce LTP by enhancing postsynaptic receptor responsiveness (Cormier et al., 1993; Cormier and Kelly, 1996) . To assess the use of the activity protocol on cultured neurons, we repeated our experiments but in the absence of exogenous BDNF. The activity protocol resulted in a significant increase in glutamate current measured at 20-25 minutes (129 ± 9% of baseline, n = 10, p < 0.05; Fig. 1D ,E). To ensure that the increase in current was stimulusdependent, we also tested the low activity protocol in the absence of BDNF. This procedure evoked no enhancement of glutamate current at 20-25 minutes (101 ± 8% of baseline, n = 7; Fig. 1D ,E). Consequently, repetitive glutamate receptor activation alone can produce a small increase in glutamate current if given at a sufficiently high frequency.
These experiments identified three conditions in which glutamate current increased to varying degrees: use of the activity protocol in the presence of BDNF (Condition 1), use of the activity protocol in the absence of BDNF (Condition 2), and use of the low activity protocol in the presence of BDNF (Condition 3). Of the three conditions, the activity protocol plus BDNF had the greatest effect. To determine whether this last response was simply an additive result of activity stimulation alone plus low activity stimulation in BDNF (i.e. Condition 2 + Condition 3), or whether it represented a synergistic action produced by co-activation of TrkB and glutamate receptors, the response to activity stimulation alone was added to low activity stimulation in BDNF (solid line, Fig. 1C ). The calculated current magnitude did not reach the level of simultaneous TrkB and glutamate receptor stimulation. Therefore, simultaneous TrkB and glutamate receptor activation acted synergistically to produce the largest increase in current.
Endogenous neurotrophins.
To gain further insight into how the activity protocol produced the enhancement of glutamate current observed in the absence of exogenously applied BDNF (Fig. 1D) , we investigated the possibility that glutamate iontophoresis stimulated release of endogenous neurotrophin that acted on glutamate receptors via "autocrine" signaling pathways (Segal and Greenberg, 1996) . BDNF is released by activity-dependent manipulations such as potassium depolarization or electrical stimulation (Lindholm et al., 1994; Goodman et al., 1996; Haubensak et al., 1998; Balkowiec and Katz, 2000; Kojima et al., 2001; Hartmann et al., 2001) . We hypothesized that the activity protocol used here increased glutamate currents by stimulating release of endogenous BDNF which then acted on the cell's intrinsic TrkB receptors. To test this hypothesis, we repeated the activity protocol in the presence of K-252a (200 nM), an inhibitor of Trk receptor tyrosine kinases (Knusel and Hefti, 1992) . As compared to stimulation alone which produced a 132 ± 9% increase in current compared to baseline (n = 7; Fig. 2 ) stimulation in the presence of K-252a produced a significantly smaller increase in current (109 ± 6% of baseline, n = 8, p < 0.05; Fig. 2 ) an effect consistent with activity-dependent release of endogenous BDNF or related neurotrophins. To investigate BDNF specifically, experiments with function-blocking anti-BDNF antibody (10 µg/ml) and TrkB-Fc (2 µg/ml) were performed. Similar to K-252a, the antibody (107 ± 5% of baseline, n = 5, p < 0.05; Fig. 2 ) and soluble receptor (101 ± 10% of baseline, n = 6, p < 0.05; Fig. 2 ) reduced the increase in glutamate current. Control recordings with K-252b (200 nM), the non-membrane permeable analog of K-252a (133 ± 7% of baseline, n = 7, p > 0.8; Fig. 2) , and heat-inactivated anti-BNDF antibody (133 ± 8% of baseline, n = 7, p > 0.9; Fig. 2 ) had no effect on the increase in current. These data suggest that activity-dependent release of endogenous BDNF was predominantly responsible for the increase in glutamate current induced by the activity protocol.
Role of calcium. Our observation that the enhancement of glutamate current produced by BDNF is activity-dependent led us to examine the mechanistic role of calcium. We employed three different manipulations to explore this issue. In each case, the activity stimulation protocol was used. First, application of BDNF during recordings performed in nominally calcium-free extracellular solution largely eliminated the increase in glutamate current (109 ± 5% of baseline, n = 6; Fig. 3) . Second, we included 10 mM BAPTA, a high affinity calcium chelator, in the recording pipette. Intracellular injection of BAPTA also strongly attenuated the action of BDNF (112 ± 7% of baseline, n = 6; Fig. 3 ). Finally, we employed a non-pharmacological approach by changing the membrane holding potential from -40mV to -80mV, a voltage that favors blockade of NMDA receptors by magnesium (Mayer and Westbrook, 1987) , thus preventing activation and calcium influx through these channels. The negative holding potential also eliminated the action of BDNF (103 ± 7% of baseline, n = 7; Fig. 3 ). Taken together, these results confirm the observation that BDNF enhancement of glutamate currents is activity-dependent and is dependent upon calcium influx.
Role of glutamate receptors. If the effect of BDNF requires co-incident activation of glutamate receptors, then it should also be prevented during the "activity" protocol if the receptors are blocked. To test this prediction, kynurenate (1 mM) was co-applied with BDNF (Fig. 4A) . During this period, the response to iontophoretically applied glutamate was substantially reduced. Upon washout of the kynurenate, the glutamate current returned to baseline without any indication of an effect of BDNF (104 ± 7% of baseline, n = 4), even though the BDNF had been applied for 25 min and glutamate pulses delivered at 0.1 Hz.
To address whether NMDA receptors are critical, we again took advantage of the voltagedependent block that affects NMDA receptors but not AMPA receptors. When neurons are held at -40 mV and the "activity" protocol is used, BDNF increased glutamate currents (Fig 1) . On the other hand, no response to BDNF was seen at a holding potential of -80 mV (Fig. 3) . This manipulation prevents calcium entry through NMDA receptors but also prevents assessment of NMDA receptor activity because they are no longer available. To determine whether NMDA receptor activity is necessary during BDNF application, responses were compared at -40 mV before and after BDNF application but cells were held at -80 mV during BDNF exposure (Fig. 4B) . During the baseline period when the holding potential was depolarized from -80 to -40 mV, the change in total glutamate current was somewhat variable, but was on average almost unchanged (103 ± 22% of baseline, n = 7) a result expected from the decrease in driving force coupled with an increase in the NMDA component of current which is relatively small under baseline conditions (Crozier et al., 1999) . During BDNF perfusion, when the glutamate current would have been expected to increase had the holding potential been kept at -40 mV, the current amplitude was similar to that seen in the pre-BDNF period (107 ± 15% of baseline, n = 7, p > 0.8; Fig. 4) . These data support the notions that NMDA receptors must be available during BDNF application to generate an increase in glutamate current and that TrkB activation alone is insufficient.
Single-channel modulation. Although previous work from our laboratory has implicated NMDA receptors as the primary target of postsynaptic BDNF enhancement of glutamate current in embryonic hippocampal neurons (Levine et al., 1998; Crozier et al., 1999) , the present results led us to address directly the question of whether calcium influx through individual NMDA receptor channels is sufficient to support BDNF modulation. We therefore made cell-attached single-channel recordings of NMDA receptor channels (Fig. 5) during which the primary source of calcium was provided via the recording pipette (i.e. calcium was omitted from the external bath solution). In agreement with a prior study (Levine et al., 1998) , BDNF applied outside of the recording pipette is capable of increasing NMDA receptor activity inside the pipette when calcium is included in the pipette solution (Fig. 5A,C,E) . The effect of BDNF began within a few minutes of application, and became maximal after 15 minutes. On average, channel activity approximately doubled (244 ± 41% above baseline, n = 10 recordings).
Consistent with the results of the whole-cell recordings, replacing calcium in the recording pipette with EGTA prevented the action of BDNF (Fig. 5B,D,E) . Without calcium influx, NMDA receptor activity remained unchanged during exposure to BDNF (116 ± 27%, n = 9) and was comparable to having calcium in the pipette but exposing the cell to the BDNF vehicle solution (91 ± 14%, n = 10, Fig. 5F ). These experiments suggest that sufficient calcium enters through the small number of NMDA receptor channels in the patch to allow for modulation of channel activity by BDNF.
The magnitude of the effect of BDNF on glutamate currents is primarily dependent on three conditions. First, simultaneous TrkB and NMDA receptor activation act synergistically to enhance glutamate current. Second, BDNF-induced enhancement of current requires elevation of intracellular calcium. Finally, the stimulation-induced increase of current results, at least in part, from endogenously released BDNF. These points are represented diagrammatically in figure 6 , which provides an overall view of the combinations of conditions used in this study. The horizontal bars at the top of figure 6A indicate the presence of activity (high frequency glutamate stimulation), elevation of intracellular calcium, and BDNF. The two black columns represent the change in glutamate current magnitude when all three manipulations were used simultaneously. It is evident that when NMDA receptors are allowed to open, the response produced exceeds that of any pairwise combination; if NMDA receptors are not allowed to open (-80 mV holding potential), then the concurrence of activity, BDNF, and extracellular calcium is without effect. Based upon these data, we propose that BDNF increases the NMDA receptor component of the total glutamate current under restricted conditions (Fig. 6B) . When comparing BDNF presentation to two neurons, one that is quiescent and one that is active, maintained TrkB signaling produces no change in NMDA receptor properties in the inactive cell but does so in the active cell. The reason is that TrkB activation alone is insufficient to influence NMDA receptor availability. When NMDA receptors are open and conducting current, however, the calcium influx is sufficient to support TrkB signaling and consequent upregulation of their own activity.
Discussion
In this study we tested the hypothesis that postsynaptic modulation of embryonic hippocampal neuron glutamate current by BDNF is activity-dependent. We examined the effect of stimulation frequency on BDNF-enhanced glutamate receptor responsiveness and found that the trophin action depended upon glutamate receptor activation. In previous studies we showed that NMDA receptor antagonists prevented the action of BDNF (Crozier et al., 1999) and that current through AMPA receptors was largely unaffected by acute application of BDNF (Levine et al., 1998) . Here we show that a holding potential of -80 mV, which would prevent opening of NMDA receptors while leaving activation of non-NMDA ionotropic and metabotropic receptors intact, also prevented the effect of BDNF on glutamate current. We propose that glutamate application elevates intracellular calcium through NMDA receptors that acts synergistically with TrkB signaling to enhance NMDA receptor activity and consequently produce an increase in glutamate current. Exposure to BDNF during low frequency stimulation, in which TrkB activation is not accompanied by repeated activation of glutamate receptors, elicits a markedly smaller response. A high spatial resolution is likely because calcium entry through individual NMDA receptor channels can support modulation. Thus, in the developing mammalian nervous system, BDNF modulation is subject to a Hebbian-like condition, requiring coordinate TrkB activation and postsynaptic activity to enhance synaptic transmission. And, in common with other forms of synaptic plasticity, NMDA receptor participation is essential.
BDNF modulation of NMDA receptors has now been found in a variety of cell types and preparations. Recordings from hippocampal neurons demonstrated BDNF-potentiated transmission due to increased NMDA receptor sensitivity (Song et al., 1998; Levine et al., 1998; Crozier et al., 1999; Kolb et al., 2005; Caldeira et al., 2007) . NMDA receptor single-channel recordings from cell-attached (Jarvis et al., One potential mechanism for BDNF-induced enhancement of glutamate currents involves elevation of intracellular calcium (Stoop and Poo, 1996; Li et al., 1998) . Calcium influx activates multiple signaling molecules, including calcium/calmodulin-dependent protein kinase II which was implicated in our previous work as an important link between TrkB activation and increased NMDA receptor function (Crozier et al., 1999) . For the modulation described here, calcium elevation is critical. Exclusion of calcium from the external solution or intracellular injection of the calcium chelator BAPTA prevented potentiation. Moreover, in single-channel recordings with and without calcium in the pipette solution, only the former showed modulation by BDNF, indicating that calcium influx through individual NMDA receptor channels is sufficient to support modulation. On their own, these experiments do not completely rule out other potential sources of elevated calcium, including release from intracellular stores or other calcium-permeable channel types including voltage-gated calcium channels. For the modest level of depolarization (-40 mV) used here, however, we regard these possibilities as unlikely. We have shown previously that BDNF enhances the current produced by iontophoretic application of NMDA, suggesting that metabotropic receptors are not required (Levine et al., 1998) . Furthermore, the response to BDNF was eliminated by application of kynurenate (Fig. 4A) which should not interfere with channel types other than glutamate receptors. Moreover, even though it has been established that BDNF can elicit an elevation of intracellular calcium (Amaral et al., 2007) our experiments indicate that this increase is not sufficient on its own to support NMDA receptor modulation since it could occur independent of glutamate application. This does not mean that other influences could not come into play, particularly at higher depolarizations, but for the NMDA receptor dependent effect of BDNF on glutamate current, the direct source is the most likely. Regardless of the source of calcium entry, the key point is that BDNF modulation of glutamate current will only occur in active neurons, because the magnesium block of NMDA receptors must be removed and because calcium elevation must occur.
Given the dramatic effects that resulted from exogenously applied BDNF, we examined possible stimulation-dependent endogenous neurotrophin action. A previous report examining chronic NMDA treatment revealed activity-dependent release of BDNF with subsequent TrkB activation (Marini et al., 1998) . Similarly, in the present study, glutamate receptor stimulation alone increased glutamate current in the absence of exogenous BDNF. This potentiation was reduced by the non-selective Trk antagonist, K-252a, suggesting neurotrophin involvement. Experiments using a function-blocking antibody to BDNF reproduced the K-252a result, suggesting that the activity protocol induced release of endogenous BDNF that then increased glutamate current. These results support the contention that BDNF can be released by glutamate receptor activity, stimulate postsynaptic TrkB receptors and enhance glutamate receptor responsiveness in an autocrine fashion in a manner strikingly similar to that of exogenously applied BDNF, albeit on a smaller scale.
Studies of BDNF-modulated LTP in the adult hippocampus have not demonstrated a requirement
for NMDA receptor activation (Xu et al., 2000) . Possible explanations for the apparent variation of effects on NMDA receptors may reside in the type and age of preparation used. In cultured embryonic hippocampal neurons, blockade of NR2B-containing NMDA receptors prevented BDNF enhancement of glutamate-induced currents (Crozier et al., 1999) and the increased activity of single NMDA receptor channels (Levine and Kolb, 2000) . NR2B-containing NMDA receptors are generally expressed at higher levels in the developing hippocampus and their relative contribution to synaptic currents subsequently diminishes in the adult (Monyer et al., 1994; Stocca and Vicini, 1998; Tovar and Westbrook, 1999) ; thus, it is possible that hippocampal slices from adult animals do not reveal effects on synaptic NMDA receptors because NR2A and NR2B subunits can become associated with different sets of synaptic molecules (AlHallaq et al., 2007) . This idea is consistent with our previous biochemical report demonstrating a BDNFinduced increase in phosphorylation of juvenile NR2B, but not NR2A subunits (Lin et al., 1998) .
The critical role played by NMDA receptors in the induction of synaptic plasticity has led us to focus our attention on postsynaptic actions of BDNF; work from other laboratories, however, has shown equally potent effects of this neurotrophin on presynaptic properties. For example, experiments on cultured hippocampal neurons (Lessmann et al., 1994; Li et al., 1998; Berninger et al., 1999; Schinder et al., 2000) revealed enhanced excitatory transmission arising from increased release of neurotransmitter.
Experiments in hippocampal and cerebellar slices demonstrated enhancement due to increased basal excitatory transmission (Kang and Schuman, 1995) or reduced inhibitory input (Frerking et al., 1998; Cheng and Yeh, 2003) . Activity-dependent processes such as LTP are also potentiated by BDNF, attributable to presynaptic mechanisms that do not require NMDA receptor activation (Figurov et al., 1996) but do require high-frequency stimulation (Gottschalk et al., 1998) . Activity-dependence has also been found in modulation of presynaptic properties by BDNF. In a non-mammalian neuromuscular synapse preparation (Boulanger and Poo, 1999) brief depolarization in the presence of low levels of BDNF produced potentiation under circumstances when neither BDNF alone nor depolarization would -a result in accord with the synergistic effect of BDNF and NMDA receptor activation reported in this study. It was hypothesized in a later study (Zhang and Poo, 2002 ) that the activity-dependence and synapsespecificity resulted from a localized response to BDNF that required local protein synthesis. The mechanism described in the present study characterizes a postsynaptic component of synapse specificity that does not require restricted release of BDNF. This mechanism will target active synapses selectively even in a uniform field of BDNF. Moreover, our single-channel recordings suggest that this effect could be highly spatially restricted since calcium through individual channels is sufficient to support responsiveness to BDNF.
The modulatory effects of BDNF influence both rapid and long-term synaptic and neurotrophin signaling. For example, several studies indicate that BDNF and depolarizing stimuli acutely increase TrkB localization at the cell surface in retinal ganglia and hippocampal neurons (Meyer-Franke et al., 1998; Du et al., 2000) . Increased TrkB surface expression may enhance a neuron's ability to compete for limited supply of neurotrophins. Relevant to the present study, at a lower stimulation frequency (0.16 Hz) relatively little change in TrkB surface expression was observed by Du et al indicating that this type of signaling may be operationally different from modulation of glutamate receptor function described by stimulation at 0.1 Hz used in this study. Also relevant is the finding that the combination of activity and BDNF was necessary for conversion of silent synapses to AMPA-containing synapses (Itami et al., 2003) .
In another study, alterations in the actual morphology of dendrites from slices of visual cortex were observed to require glutamate receptor activation that were manifested over 36 hours in culture (McAllister et al., 1996) . Together with the results presented here, these studies may highlight two separate phases of BDNF activity; one an early rapid phase on transmitter receptors and a later phase that may effect long-term signaling and connectivity.
For the mechanism of action, it is clear that near concomitant NMDA receptor opening and TrkB activation is critical. Although the two need not occur simultaneously, our results imply that if TrkB activation does not occur while calcium-potentiated signaling is enabled, then NMDA receptor activity will not be upregulated. In terms of the signaling pathways, the low affinity trk receptor, p75, is not likely to be involved (Reichardt, 2006) . This conclusion is supported by studies which show that p75 and TrkB activation have opposite effects (Kim et al., 2003; Sandoval et al., 2007) making it less likely that p75 participates in the enhancement of NMDA receptor activity. The effect of BDNF reported here is also unlikely to be mediated by binding to the glycine site (Jarvis et al., 1997) because it can be blocked by K252a and can be observed in cell-attached single-channel recordings (Levine et al., 1998) . The requirement for calcium could be present at different levels in the many signaling cascades initiated by BDNF binding to TrkB. Our past work has implicated CaMKII (Crozier et al., 1999) which would be a good starting target for future work to elucidate the calcium-dependence.
Activity-dependence may confer specificity of neurotrophin synaptic action. Although the exact source of BDNF release is not yet known, it may not always be subject to precise targeting. The activitydependence described here provides a mechanism for synapse specificity; increased glutamate current depends on conjoint elevation of calcium via NMDA receptors and TrkB stimulation in synaptic terminals. Thus exposure of active synapses to BDNF results in a reinforcement of that activity, which may consequently lead to maintenance and integration of those synapses into mature circuits. or low activity (traces on right) stimulation protocols. BDNF was not present during stimulation although cells were perfused with the BDNF vehicle solution in the same way as for BDNF. The activity protocol evoked a modest increase in glutamate current whereas the low activity protocol had no effect. E. Averaged time course of response to BDNF (n = 7 recordings). The holding potential was maintained at -80 mV except for the two indicated periods at -40 mV to assess the NMDA receptor component of current.
As a result of changing the holding potential during these periods, the average amplitude of glutamate current increased slightly prior to BDNF perfusion and increased by a similar amount during BDNF perfusion. The data further support the conclusion that NMDA receptors are not being affected by BDNF in the absence of calcium influx. replacing Ca with EGTA in the pipette solution resulted in no effect of BDNF on NMDAR activity. E.
Plot in which Po values have been combined into 1 minute bins and normalized to baseline activity.
Experiments in which calcium was present in the pipette solution and which were exposed to BDNF show elevated activity (filled circles, n = 10). Experiments in which the pipette contained calcium but were exposed to BDNF vehicle solution did not (open squares, n = 10). Experiments in which patches were exposed to BDNF but contained EGTA instead of calcium in the pipette solution also showed no increase in activity (inverted triangles, n = 9). F. Summary graph in which average activity at 15 -20 min during the BDNF perfusion is plotted. Addition of BDNF elicited a significant increase in activity as compared to vehicle when calcium was in the pipette solution (asterisk, p < 0.01) but not when EGTA was in the pipette solution (p > 0.4). 
